Quetiapine-associated acute dystonia [2]

Annals of Pharmacotherapy

Volumn 38, Issue 4, 2004, Pages 719-720

  Kropp, Stefan ^a   Hauser, Ute ^a   Ziegenbein, Marc ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ANTIBIOTIC AGENT; BIPERIDEN; CERULOPLASMIN; CLOZAPINE; COPPER; CYTOCHROME P450 3A4; NEUROLEPTIC AGENT; PROLACTIN; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; AMENORRHEA; CASE REPORT; DELUSION; DISORIENTATION; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GALACTORRHEA; HALLUCINATION; HEAD MOVEMENT; HUMAN; LETTER; MENSTRUATION; MUSCLE RIGIDITY; PRIORITY JOURNAL; SCHIZOPHRENIA; SIDE EFFECT; WEIGHT GAIN;

EID: 1542638810     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D411     Document Type: Letter

References (6)

1. Gunasekara NS, Spencer CM. Quetiapine. A review of its use in schizophrenia. CNS Drugs 1998;9:325-40.
2. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1999.
3. Raja M, Azzoni A. Novel antipsychotics and acute dystonic reactions. Int J Neuropsychopharmacol 2001;4:393-7.
4. Cunningham Owens DG. A guide to extrapyramidal side-effects of antipsychotic drugs. Cambridge University Press, 1999.
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
6. Ghaemi SN, Ko JY. Quetiapine-related tardive dyskinesia (letter). Am J Psychiatry 2001;158:1737.